Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Grégoire

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Clinical Therapeutics|February 16, 2010
Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysisJocelyne Moisan, Jean-Pierre Grégoire
Therapeutic Advances in Drug Safety|August 2, 2014
Acetylsalicylic acid for primary prevention of cardiovascular diseases in older patients with diabetes: do the benefits overcome the risks?Caroline Sirois, Julie Couture, Jean-Pierre Grégoire
The Journal of Clinical Psychiatry|June 27, 2007
Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophreniaDan Cooper, Jocelyne Moisan, Jean-Pierre Grégoire
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 16, 2018
Risk of pulmonary toxicity of bleomycin and filgrastimMagali Laprise-Lachance, Pierre Lemieux, Jean-Pierre Grégoire
Vaccine|May 4, 2004
The societal value of universal childhood vaccinationIsabelle Chabot, Mireille M Goetghebeur, Jean-Pierre Grégoire
Research in Social & Administrative Pharmacy : RSAP|March 26, 2013
Community pharmacy loyalty among individuals with schizophreniaSophie Lauzier, Jean-Pierre Grégoire, Alain Lesage, et al.
Pharmacoeconomics|April 8, 2003
Cost-benefit model comparing two alternative immunisation programmes against serogroup C meningococcal disease: for Quebec residents aged 2 months to 20 yearsCarol Rancourt, Jean-Pierre Grégoire, W Simons, et al.
Canadian Journal of Diabetes|October 29, 2015
Predictive Validity of Self-Reported Measures of Adherence to Noninsulin Antidiabetes Medication against Control of Glycated Hemoglobin LevelsArsène Zongo, Line Guénette, Jocelyne Moisan, et al.
Research in Social & Administrative Pharmacy : RSAP|September 27, 2018
Measuring adherence to oral antidiabetic multi-drug treatment: Comparative validity of prescription claims-based adherence measures against hospitalizationArsène Zongo, Jean-Pierre Grégoire, Jocelyne Moisan, et al.
Annals of Medicine|May 3, 2014
Myocardial infarction and gastro-intestinal bleeding risks associated with aspirin use among elderly individuals with type 2 diabetesCaroline Sirois, Jocelyne Moisan, Paul Poirier, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Clinical Therapeutics|February 16, 2010
Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysisJocelyne Moisan, Jean-Pierre Grégoire
Therapeutic Advances in Drug Safety|August 2, 2014
Acetylsalicylic acid for primary prevention of cardiovascular diseases in older patients with diabetes: do the benefits overcome the risks?Caroline Sirois, Julie Couture, Jean-Pierre Grégoire
The Journal of Clinical Psychiatry|June 27, 2007
Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophreniaDan Cooper, Jocelyne Moisan, Jean-Pierre Grégoire
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 16, 2018
Risk of pulmonary toxicity of bleomycin and filgrastimMagali Laprise-Lachance, Pierre Lemieux, Jean-Pierre Grégoire
Vaccine|May 4, 2004
The societal value of universal childhood vaccinationIsabelle Chabot, Mireille M Goetghebeur, Jean-Pierre Grégoire
Research in Social & Administrative Pharmacy : RSAP|March 26, 2013
Community pharmacy loyalty among individuals with schizophreniaSophie Lauzier, Jean-Pierre Grégoire, Alain Lesage, et al.
Pharmacoeconomics|April 8, 2003
Cost-benefit model comparing two alternative immunisation programmes against serogroup C meningococcal disease: for Quebec residents aged 2 months to 20 yearsCarol Rancourt, Jean-Pierre Grégoire, W Simons, et al.
Canadian Journal of Diabetes|October 29, 2015
Predictive Validity of Self-Reported Measures of Adherence to Noninsulin Antidiabetes Medication against Control of Glycated Hemoglobin LevelsArsène Zongo, Line Guénette, Jocelyne Moisan, et al.
Research in Social & Administrative Pharmacy : RSAP|September 27, 2018
Measuring adherence to oral antidiabetic multi-drug treatment: Comparative validity of prescription claims-based adherence measures against hospitalizationArsène Zongo, Jean-Pierre Grégoire, Jocelyne Moisan, et al.
Annals of Medicine|May 3, 2014
Myocardial infarction and gastro-intestinal bleeding risks associated with aspirin use among elderly individuals with type 2 diabetesCaroline Sirois, Jocelyne Moisan, Paul Poirier, et al.
Pageof 8